Inventor
PEIXOTO CHRISTOPHE
FR19 patents
⚠️ This page may combine multiple inventors who share the name “PEIXOTO CHRISTOPHE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GALAPAGOS NV
17 patentsUS9249141B2Feb 2, 2016
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV9 citations91
US10526329B2Jan 7, 2020
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV4 citations83
US10125132B2Nov 13, 2018
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV6 citations83
US9670204B2Jun 6, 2017
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV10 citations83
US8993590B2Mar 31, 2015
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV8 citations83
US9926281B2Mar 27, 2018
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV6 citations81
US11072611B2Jul 27, 2021
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV2 citations72
US10487060B2Nov 26, 2019
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV4 citations70
US11339166B2May 24, 2022
Compounds and pharmaceutical compositions thereof for the treatment of diseases
GALAPAGOS NV2 citations68
US11718588B2Aug 8, 2023
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV0 citations59
US10941117B2Mar 9, 2021
5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis
GALAPAGOS NV0 citations59
US12065443B2Aug 20, 2024
Compounds and pharmaceutical compositions thereof for the treatment of diseases
GALAPAGOS NV0 citations58
US7968581B2Jun 28, 2011
Imidazolidine compounds as androgen receptor modulators
GALAPAGOS NV2 citations58
US9796719B2Oct 24, 2017
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GALAPAGOS NV1 citations51
US12264156B2Apr 1, 2025
Compounds and pharmaceutical compositions thereof for the treatment of diseases
GALAPAGOS NV0 citations46
US10829478B2Nov 10, 2020
5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritis
GALAPAGOS NV0 citations37
US10550100B2Feb 4, 2020
5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritis
GALAPAGOS NV0 citations37